跳转到内容

氢吗啡酮

维基百科,自由的百科全书
氢吗啡酮
Structural formula of hydromorphone
Space-filling model of hydromorphone
臨床資料
商品名英语Drug nomenclatureDilaudid, Palladone, others
其他名稱Dihydromorphinone
AHFS/Drugs.comMonograph
MedlinePlusa682013
核准狀況
懷孕分級
依賴性High[2]
成癮性High[3]
给药途径By mouth, intramuscular, intravenous, subcutaneous
藥物類別英语Drug classOpioid
ATC碼
法律規範狀態
法律規範
藥物動力學數據
生物利用度By mouth: 30–35%, Intranasal: 52–58%,[4] IV/IM: 100%
血漿蛋白結合率20%
药物代谢
藥效起始時間英语Onset of action15-30分钟[5]
生物半衰期2–3 hours[6]
作用時間4 to 5 hrs[5]
排泄途徑Kidney
识别信息
  • 4,5-α-Epoxy-3-hydroxy-17-methyl morphinan-6-one
CAS号466-99-9  checkY
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.006.713 編輯維基數據鏈接
化学信息
化学式C17H19NO3
摩尔质量285.34 g·mol−1
3D模型(JSmol英语JSmol
水溶性HCl salt: 333
  • O=C4[C@@H]5Oc1c2c(ccc1O)C[C@H]3N(CC[C@]25[C@H]3CC4)C
  • InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1 checkY
  • Key:WVLOADHCBXTIJK-YNHQPCIGSA-N checkY

氢吗啡酮(英語:hydromorphone,也称为二氢吗啡酮,dihydromorphinone,商品名:Dilaudid)是一种含氮有机化合物,化学式C17H19NO3,是一种用于缓解中度至重度疼痛吗啡喃類阿片药物[5]

参考文献

[编辑]
  1. ^ Hydromorphone Use During Pregnancy. Drugs.com. 19 November 2019 [16 May 2020]. (原始内容存档于2020-11-26). 
  2. ^ Bonewit-West K, Hunt SA, Applegate E. Today's Medical Assistant: Clinical and Administrative Procedures. Elsevier Health Sciences. 2012: 571 [2024-02-12]. ISBN 9781455701506. (原始内容存档于2023-01-10) (英语). 
  3. ^ Bonewit-West K, Hunt SA, Applegate E. Today's Medical Assistant: Clinical and Administrative Procedures. Elsevier Health Sciences. 2012: 571 [20 August 2019]. ISBN 9781455701506. (原始内容存档于10 January 2023). 
  4. ^ Coda BA, Rudy AC, Archer SM, Wermeling DP. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers. Anesthesia and Analgesia. July 2003, 97 (1): 117–23, table of contents. CiteSeerX 10.1.1.551.6509可免费查阅. PMID 12818953. S2CID 22694749. doi:10.1213/01.ANE.0000066311.40978.4F. 
  5. ^ 5.0 5.1 5.2 Hydromorphone Hydrochloride Monograph for Professionals. Drugs.com. American Society of Health-System Pharmacists. [15 April 2019]. (原始内容存档于2019-06-01) (英语). 
  6. ^ Vallner JJ, Stewart JT, Kotzan JA, Kirsten EB, Honigberg IL. Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. Journal of Clinical Pharmacology. April 1981, 21 (4): 152–156. PMID 6165742. S2CID 29864565. doi:10.1002/j.1552-4604.1981.tb05693.x. 
  7. ^ Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 31 March 2023 (4 April 2023) [16 August 2023]. (原始内容存档于3 August 2023) (巴西葡萄牙语). 

外部链接

[编辑]